A 71-year-old male patient with a history of insulin-dependent diabetes & cardiovascular disease presents w/ a diagnosis of microcystic adnexal carcinoma on his forehead
Problem list:
Co-morbid patient w/ cardiovascular disease
Complete clearance of microcystic adnexal carcinoma
A 71-year-old male patient with a history of insulin-dependent diabetes & cardiovascular disease presents w/ a diagnosis of microcystic adnexal carcinoma on his forehead
Problem list:
Co-morbid patient w/ cardiovascular disease
Complete clearance of microcystic adnexal carcinoma
#PRSJournalClub Facebook Q&A is BACK on Sunday, March 27th!
Join Drs. Marano & Rohde as they discuss, โComparing Outcomes after #BreastReduction,โ on the #PRSJournal's Facebook page!
Read the paper now: https://t.co/Ljvv1LYmV1
Read the Collection: https://t.co/U9PK4vDPCd
Congratulations to the NEW members of this quarter's #PRSJournal and @PRSGlobalOpen Resident Advisory Board!
We are excited to work with such a broad and diverse group of #plasticsurgery residents!
Learn more and sign up to get involved: https://t.co/VXLRW5mEk6
Israel - updated status May_2:
๐
~59% (graph)
๐คง
* <8 infections /M/d (>100-fold drop)
>30k tests /d
10% imported
* 5 days w 0-1 deaths past wk!
๐ท
Schools open >1m - v few outbreaks
Masks off in open areas
Green passes (high-risk setting) - w no outbreaks!
#VaccinesWork!
.@Pfizer & governments around the world are working on longer-term pandemic preparedness. Today we signed our first 2022 government agreement with Israel to supply millions of doses of the Pfizer-BioNTech #COVID19 vaccine with the option to purchase millions of additional doses.
Israel ๐๐ท- Milestones achieved this week:
* 0 daily infections in nursing homes
* 0 cities marked โredโ in the national Covid-19 scale
* 7 days w/ <100 daily cases /1,000 (5 of which <70)
* <500 cases hospitalized
* 1 death /1,000,000
Happy Passover!
https://t.co/1zetCOQrWl
Israel: Continuing to crush the curve
The economy is nearly fully open
R continues to decline, now at its lowest ever: 0.55
This corresponds to a 65% weekly decline in daily cases
Today we announced important data from our comprehensive public health surveillance program in @Israel that confirmed high-effectiveness of the Pfizer/BioNTech #COVID19 vaccine: https://t.co/906IiZolmE (1/5)
Exclusive: an initial analysis by Israel's largest healthcare provider Clalit shows a 33% drop in covid-19 infections, 14 days after 1st dose. Pfizer phase 3 trial checked for symptomatic disease only. This analysis was done on over 200,000 people 60+. Done by @RanBalicer